These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 193663

  • 1. Inhibition of the in vitro outgrowth of Epstein-Barr virus-transformed lymphocytes by thymus-dependent lymphocytes from infectious mononucleosis patients.
    Rickinson AB, Crawford D, Epstein MA.
    Clin Exp Immunol; 1977 Apr; 28(1):72-9. PubMed ID: 193663
    [Abstract] [Full Text] [Related]

  • 2. Cytotoxic T cell recognition of Epstein-Barr virus-infected B cells. I. Specificity and HLA restriction of effector cells reactivated in vitro.
    Moss DJ, Wallace LE, Rickinson AB, Epstein MA.
    Eur J Immunol; 1981 Sep; 11(9):686-93. PubMed ID: 6170517
    [Abstract] [Full Text] [Related]

  • 3. The suppression of Epstein-Barr virus infection in vitro occurs after infection but before transformation of the cell.
    Thorley-Lawson DA.
    J Immunol; 1980 Feb; 124(2):745-51. PubMed ID: 6243331
    [Abstract] [Full Text] [Related]

  • 4. The MLC response of patients with infectious mononucleosis to Epstein-Barr virus-transformed cells.
    Wasik M, Myc A, Matej H, Rudzka L.
    Arch Immunol Ther Exp (Warsz); 1983 Feb; 31(6):871-8. PubMed ID: 6331340
    [Abstract] [Full Text] [Related]

  • 5. In vitro expansion of Epstein-Barr virus-specific HLA-restricted cytotoxic T cells direct from the blood of infectious mononucleosis patients.
    Strang G, Rickinson AB.
    Immunology; 1987 Dec; 62(4):647-54. PubMed ID: 2828228
    [Abstract] [Full Text] [Related]

  • 6. Characterization of thymus-derived lymphocyte subsets in acute Epstein-Barr virus-induced infectious mononucleosis.
    Haynes BF, Schooley RT, Grouse JE, Payling-Wright CR, Dolin R, Fauci AS.
    J Immunol; 1979 Feb; 122(2):699-702. PubMed ID: 216749
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Long-term T-cell-mediated immunity to Epstein-Barr virus.
    Rickinson AB, Moss DJ, Wallace LE, Rowe M, Misko IS, Epstein MA, Pope JH.
    Cancer Res; 1981 Nov; 41(11 Pt 1):4216-21. PubMed ID: 6272965
    [No Abstract] [Full Text] [Related]

  • 12. Suppressor T cell clones from patients with acute Epstein-Barr virus-induced infectious mononucleosis.
    Wang F, Blaese RM, Zoon KC, Tosato G.
    J Clin Invest; 1987 Jan; 79(1):7-14. PubMed ID: 3025263
    [Abstract] [Full Text] [Related]

  • 13. B lymphocytopenia in infectious mononucleosis.
    Sumaya CV, Keightley RG.
    Clin Exp Immunol; 1981 Feb; 43(2):298-301. PubMed ID: 6268336
    [Abstract] [Full Text] [Related]

  • 14. Epstein Barr virus-specific immune defects in patients with persistent symptoms following infectious mononucleosis.
    Borysiewicz LK, Haworth SJ, Cohen J, Mundin J, Rickinson A, Sissons JG.
    Q J Med; 1986 Feb; 58(226):111-21. PubMed ID: 3012622
    [Abstract] [Full Text] [Related]

  • 15. Recruitment during infectious mononucleosis of CD3+CD4+CD8+ virus-specific cytotoxic T cells which recognise Epstein-Barr virus lytic antigen BHRF1.
    White CA, Cross SM, Kurilla MG, Kerr BM, Schmidt C, Misko IS, Khanna R, Moss DJ.
    Virology; 1996 May 15; 219(2):489-92. PubMed ID: 8638417
    [Abstract] [Full Text] [Related]

  • 16. Regulatory T cell activity in primary and persistent Epstein-Barr virus infection.
    Wingate PJ, McAulay KA, Anthony IC, Crawford DH.
    J Med Virol; 2009 May 15; 81(5):870-7. PubMed ID: 19319950
    [Abstract] [Full Text] [Related]

  • 17. Blastogenic response of purified human T-lymphocyte populations to Epstein-Barr virus (EBV).
    Gergely P, Ernberg I, Klein G, Steinitz M.
    Clin Exp Immunol; 1977 Dec 15; 30(3):347-53. PubMed ID: 203426
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. T cell-mediated immunoregulation of Epstein Barr virus- (EBV) induced B lymphocyte activation in EBV-seropositive and EBV-seronegative individuals.
    Tosato G, Magrath IT, Blaese RM.
    J Immunol; 1982 Feb 15; 128(2):575-9. PubMed ID: 6274959
    [Abstract] [Full Text] [Related]

  • 20. Enhanced destruction of lymphoid cell lines by peripheral blood leukocytes taken from patients with acute infectious mononucleosis.
    Hutt LM, Huang YT, Dascomb HE, Pagano JS.
    J Immunol; 1975 Jul 15; 115(1):243-8. PubMed ID: 168255
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.